Sapphire Star Partners’s Mesa Laboratories MLAB Stock Holding History

Sapphire Star Partners’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$1.2M	Buy	5,767 +148	+3%	+$28.9K	1.61%	13
2018 Q3	$1.04M	Buy	5,619 +268	+5%	+$53.9K	1.05%	30
2018 Q2	$1.13M	Buy	5,351 +397	+8%	+$69.5K	1.17%	21
2018 Q1	$735K	Buy	4,954 +107	+2%	+$14.6K	0.81%	43
2017 Q4	$602K	Buy	4,847 +3,268	+207%	+$457K	0.71%	48
2017 Q3	$235K	Sell	1,579 -525	-25%	-$74.1K	0.3%	68
2017 Q2	$302K	Sell	2,104 -473	-18%	-$67.2K	0.38%	42
2017 Q1	$316K	Buy	2,577 +207	+9%	+$25.3K	0.36%	52
2016 Q4	$291K	Buy	+2,370	New	+$296K	0.32%	56

Other funds holding MLAB

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sapphire Star Partners's MLAB Position: Q4 2018 in Review

Sapphire Star Partners increased its Mesa Laboratories (MLAB) stake by 2.6% in Q4 2018, buying an estimated $28.9K and bringing the position to 5,767 shares worth $1.2M. The position accounts for 1.61% of the portfolio, ranked #13.

Sapphire Star Partners first reported a position in MLAB in Q4 2016 and has held it in 9 quarters since. 109 funds tracked by Wall St. Rank hold MLAB as of Q4 2018.

Sapphire Star Partners held 5,767 shares of Mesa Laboratories worth $1.2M as of Q4 2018.
Sapphire Star Partners bought 148 Mesa Laboratories shares in Q4 2018, an estimated $28.9K.
Mesa Laboratories made up 1.61% of Sapphire Star Partners's portfolio in Q4 2018, its #13 holding.
Sapphire Star Partners first reported a position in Mesa Laboratories in Q4 2016 and has held it in 9 quarters since.
109 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2018.

Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.